FindTrial
Sign In

dual target CAR-T cell therapy

BIOLOGICAL2 trials

Sponsors

Shenzhen University General Hospital, YuLi

Conditions

B ALLDual-target CAR-T CellsLymphoma, B-CellRefractory B Acute Lymphoblastic LeukemiaRefractory LymphomaRelapseRelapse/Recurrence

Phase 1

Dual Target CAR-T Cells in B-cell Acute Lymphoblastic Leukemia
NCT04723901
Shenzhen University General HospitalB ALL, Dual-target CAR-T Cells, Refractory B Acute Lymphoblastic Leukemia +1
Start: 2020-10-20End: 2022-12-31Target: 20Updated: 2021-01-26
Dual Target CAR-T Cells in B-cell Lymphoma
NCT04723914
YuLiDual-target CAR-T Cells, Lymphoma, B-Cell, Refractory Lymphoma +1
Start: 2020-10-20End: 2022-12-31Target: 20Updated: 2021-01-26